Latest news
Business Update
Kopfwehzentrum Hirslanden joins Priority Access Program
We are happy to welcome the Kopfwehzentrum Hirslanden as an early adopter of our Priority Access Program for migraine patients!
04 December, 2024
Read more
Featured | Tue 04, 2024
Bottneuro's Miamind Neurostimulator Spotlighted in Uni Basel Article
Bottneuro's Miamind® Neurostimulator has been featured in an article published by the University of Basel.
Events & Conferences | Mon 03, 2024
Bottneuro at the LSIUSA24
Alois Hopf, CSO of Bottneuro, is representing Bottneuro AG at the LSIUSA24 in Dana Point, California.
Business Update | Fri 03, 2024
MINDSTIM study has successfully concluded
Our first clinical trial, MINDSTIM has successfully concluded!
Business Update | Mon 03, 2024
Start of the intervention phase of the MINDSTIM study
Our very first devices are now complete and ready for the intervention phase of the MINDSTIM clinical trial with our personalized neurostimulator at t...
Featured news
